# Forensic Dossier: Study Forensics: APJ agonist as pharmacological exercise mimetic

**Run ID:** `mech_study-forensics-030_claude_opus_36eee1`  
**Task:** study-forensics-030 | study_forensics | medium | study_forensics  
**Timestamp:** 2026-04-06T15:45:19.625202+00:00  
**Task Family:** mechanism_vs_evidence  
**Trap Type:** preclinical_to_therapeutic_leap  
**Ambiguity:** low  

## Executive Summary

**Agents tested:** Claude Opus
**Winner:** Claude Opus — **67.1/100** (margin: 0.0)
**Failure modes:** unsupported_conclusion, unsupported_intermediate_step, unused_assumption
**Forensic flags:** 3
**Consistency findings:** 6
**Answer convergence:** all agents agree

## Score Matrix

| Agent | Correctness | Support Strength | Structural Reaso | Assumption Disci | Uncertainty Hand | Alternative Hypo | Self Monitoring  | Insight Depth | Mechanism Qualit | Communication Ef | **Total** |
|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|
| Claude Opus | 30.0/30 | 0.0/8 | 4.8/8 | 4.3/6 | 3.9/6 | 4.5/6 | 1.6/8 | 8.0/8 | 0.0/10 | 10.0/10 | **67.1/100** |

## Study Forensics Audit

### Claude Opus

**Classification:** `mechanism_vs_evidence` [+] (gold: `mechanism_vs_evidence`)
**Finding Recall:** 100%
**Matched Findings:** mechanism_not_demonstrated, conclusion_exceeds_results
**Extra Findings:** cautious_scope_control

## Reasoning Integrity Audit

### Claude Opus
**Classification:** Correct but brittle reasoning
**Load-bearing steps:** 0 / 5

## Mechanism Analysis

### Claude Opus
| Aspect | Status |
|--------|--------|
| Concept named | :x: none |
| Mechanism described | :x: (0 sentence(s)) |
| Grounded to case | :x: (0 sentence(s)) |

**Missing:** concept not named, mechanism not described, mechanism not grounded to case data

## Grounding Audit

### Claude Opus
Conclusion claims: 1
- Direct support: 0
- Indirect support: 0
- Unsupported: 1
- Contradicted: 0

**Unsupported claims:**
- "mechanism_vs_evidence"


## Forensic Flags

### Claude Opus

- **[MODERATE]** `weak_mechanism`: Correct answer but weak mechanism explanation — answer may not generalize
  - `final_answer`: "mechanism_vs_evidence"
- **[MAJOR]** `unsupported_leap`: Correct answer with weak support chain — final answer may be an unsupported leap
- **[MODERATE]** `unsupported_conclusion_claims`: 1/1 conclusion claims lack step support
  - `final_answer`: "mechanism_vs_evidence"


## Evidence Map

### Claude Opus

**Correctness:** 30.0/30
  - (+) `final_answer`: "mechanism_vs_evidence"
    _Agent's answer for correctness check_
  - Note: Exact match

**Support Strength:** 0.0/8
  - (-) `final_answer`: "mechanism_vs_evidence"
    _Conclusion not supported by steps_
  - Note: Support classification: 0 load-bearing, 0 supporting, 0 mentioned / 5
  - Note: Reasoning graph: conclusion not well grounded

**Structural Reasoning:** 4.8/8
  - (+) `steps[3]`: "Recognized that while the mouse data appears robust (specific metrics like HbA1c, weight loss, cardiac hypertrophy), no "
    _Most informative reasoning step_
  - Note: 5 reasoning steps
  - Note: Low step utility: 0/5 steps contribute

**Assumption Discipline:** 4.3/6
  - (+) `assumptions[1]`: "The company is making claims about human therapeutic potential based on preclinical data"
    _Most substantive assumption_
  - (-) `assumptions[2]`: "The apelin/APJ pathway functions similarly in mice and humans"
    _Declared but unused in reasoning_
  - Note: 4/4 substantive assumptions
  - Note: 1 unused assumption(s)

**Uncertainty Handling:** 3.9/6
  - (+) `uncertainties[3]`: "The extent of the company's actual claims versus the report's interpretation"
    _Most substantive uncertainty_
  - (+) `confidence`: "confidence: 0.9"
    _Stated confidence level_
  - Note: 4 uncertainties (4 substantive)
  - Note: Confidence 0.9

**Alternative Hypothesis Quality:** 4.5/6
  - (+) `alternative_hypotheses[1]`: "overclaim - the 'exercise mimetic' claim might exceed even the mouse evidence"
    _Most substantive alternative hypothesis_
  - Note: 2 alternative hypotheses considered
  - Note: 2/2 genuinely diverse alternatives

**Self Monitoring Quality:** 1.6/8
  - (+) `self_check[2]`: "The issue is specifically about translating mechanism from mice to humans, not about the quality of the preclinical work"
    _Most substantive self-verification step_
  - (-) `self_check[0]`: "Did not fabricate problems with the mouse studies themselves"
    _Fluff self-check_
  - Note: 3 self-check items
  - Note: Self-check quality: 0 deep, 1 arithmetic, 2 fluff

**Mechanism Quality:** 0.0/10
  - Note: Neither names concept nor explains mechanism

**Communication Efficiency:** 10.0/10
  - Note: Signal density: 0.75, 237 words

**Insight Depth:** 8.0/8
  - Note: Key insights: 2 full / 2


## Failure Analysis

### Claude Opus

**MODERATE:**
- **Unsupported Conclusion** `[MEDIUM CONFIDENCE]`: Final answer lacks load-bearing or supporting step grounding
  - `final_answer`: "mechanism_vs_evidence"
  - _Impacts: support_strength_
- **Unsupported Intermediate Step** `[MEDIUM CONFIDENCE]`: No reasoning step is load-bearing — final answer lacks traceable derivation
  - `final_answer`: "mechanism_vs_evidence"
  - _Impacts: support_strength, structural_reasoning_

**STYLISTIC:**
- **Unused Assumption** `[HEURISTIC]`: Assumption 'The apelin/APJ pathway functions similarly in mice and human...' is declared but not referenced in reasoning
  - `assumptions[2]`: "The apelin/APJ pathway functions similarly in mice and humans"
  - _Impacts: assumption_discipline_


## Consistency & Grounding Audit

### Claude Opus

- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 1 has low overlap with final answer (1/7 content words)
  - `key_claims[0]`: "Strong preclinical evidence in multiple mouse disease models"
- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 2 has low overlap with final answer (1/7 content words)
  - `key_claims[1]`: "Clear mechanism-to-human therapeutic leap without human evidence"
- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 3 has low overlap with final answer (0/8 content words)
  - `key_claims[2]`: "The 'exercise hormone' and 'exercise mimetic' framing implies human relevance not yet demonstrated"
- **[WARN]** `[HEURISTIC]` `unused_assumption`: Assumption 3 appears unused in reasoning or answer
  - `assumptions[2]`: "The apelin/APJ pathway functions similarly in mice and humans"
- **[NOTE]** `[HEURISTIC]` `weak_alternative`: Alternative hypothesis 1 is stated without rejection reasoning
  - `alternative_hypotheses[0]`: "solid - if we consider this purely as a preclinical report"
- **[NOTE]** `[HEURISTIC]` `weak_alternative`: Alternative hypothesis 2 is stated without rejection reasoning
  - `alternative_hypotheses[1]`: "overclaim - the 'exercise mimetic' claim might exceed even the mouse evidence"


## Agent Profiles

### Claude Opus (claude-opus-4-20250514)
**Parse OK:** True | **Latency:** 14437ms

**Final Answer:** mechanism_vs_evidence

**Confidence:** 0.9

**Assumptions:**
- The study was conducted entirely in mouse models
- The company is making claims about human therapeutic potential based on preclinical data
- The apelin/APJ pathway functions similarly in mice and humans
- The press report accurately represents the company's claims

**Reasoning Steps:**
1. Identified that all reported results are from mouse models (obese/diabetic mice, heart-failure model)
2. Noted the company's claim about 'pharmacological exercise mimetic' potential
3. Observed the leap from mouse data to human therapeutic claims ('preparing to translate the approach into human trials')
4. Recognized that while the mouse data appears robust (specific metrics like HbA1c, weight loss, cardiac hypertrophy), no human evidence is presented
5. The 'exercise hormone' framing suggests human relevance without human data

**Key Claims:**
- Strong preclinical evidence in multiple mouse disease models
- Clear mechanism-to-human therapeutic leap without human evidence
- The 'exercise hormone' and 'exercise mimetic' framing implies human relevance not yet demonstrated

**Alternative Hypotheses:**
- solid - if we consider this purely as a preclinical report
- overclaim - the 'exercise mimetic' claim might exceed even the mouse evidence

**Uncertainties:**
- Whether the company has unpublished human data
- How well the apelin/APJ pathway is conserved between mice and humans
- Whether 'preparing to translate' implies they acknowledge the evidence gap
- The extent of the company's actual claims versus the report's interpretation

**Self-Verification:**
- Did not fabricate problems with the mouse studies themselves
- Correctly identified the species gap between evidence and claims
- The issue is specifically about translating mechanism from mice to humans, not about the quality of the preclinical work

**Dimension Scores:**
- Correctness: 30.0/30 `##########`
- Support Strength: 0.0/8 `..........`
- Structural Reasoning: 4.8/8 `######....`
- Assumption Discipline: 4.3/6 `#######...`
- Uncertainty Handling: 3.9/6 `######....`
- Alternative Hypothesis Quality: 4.5/6 `#######...`
- Self Monitoring Quality: 1.6/8 `##........`
- Insight Depth: 8.0/8 `##########`
- Mechanism Quality: 0.0/10 `..........`
- Communication Efficiency: 10.0/10 `##########`


## Final Verdict

**Solo run: Claude Opus** scored **67.1/100**.

**Best per dimension:**
- Correctness: Claude Opus (30.0/30)
- Support Strength: Claude Opus (0.0/8)
- Structural Reasoning: Claude Opus (4.8/8)
- Assumption Discipline: Claude Opus (4.3/6)
- Uncertainty Handling: Claude Opus (3.9/6)
- Alternative Hypothesis Quality: Claude Opus (4.5/6)
- Self Monitoring Quality: Claude Opus (1.6/8)
- Insight Depth: Claude Opus (8.0/8)
- Mechanism Quality: Claude Opus (0.0/10)
- Communication Efficiency: Claude Opus (10.0/10)

**Latency vs Quality:**

| Agent | Latency | Score | Points/sec |
|-------|---------|-------|------------|
| Claude Opus | 14.4s | 67.1/100 | 4.6 |

Failure modes observed: unsupported_conclusion, unsupported_intermediate_step, unused_assumption.
